Hinge Health, Inc. HNGE
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 234.97M | 212.82M | 182.31M | 170.73M | 154.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 234.97M | 212.82M | 182.31M | 170.73M | 154.21M |
| Cost of Revenue | 30.43M | 28.82M | 27.97M | 26.55M | 27.97M |
| Gross Profit | 204.54M | 183.99M | 154.34M | 144.17M | 126.24M |
| SG&A Expenses | 116.53M | 109.45M | 91.13M | 84.02M | 100.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 134.00K | 45.00K | 1.51M | 147.00K | 40.00K |
| Total Operating Expenses | 184.57M | 172.38M | 150.24M | 143.47M | 160.30M |
| Operating Income | 50.41M | 40.44M | 32.07M | 27.26M | -6.09M |
| Income Before Tax | 53.72M | 44.43M | 35.94M | 32.22M | -1.64M |
| Income Tax Expenses | -3.68M | 740.00K | 814.00K | 122.00K | 206.00K |
| Earnings from Continuing Operations | 57.40M | 43.69M | 35.13M | 32.10M | -1.84M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.40M | 43.69M | 35.13M | 32.10M | -1.84M |
| EBIT | 50.41M | 40.44M | 32.07M | 27.26M | -6.09M |
| EBITDA | 51.83M | 40.90M | 32.54M | 27.78M | -5.53M |
| EPS Basic | 0.71 | 0.55 | 0.43 | 0.40 | -0.02 |
| Normalized Basic EPS | 0.42 | 0.35 | 0.29 | 0.25 | -0.01 |
| EPS Diluted | 0.66 | 0.52 | 0.41 | 0.38 | -0.02 |
| Normalized Diluted EPS | 0.39 | 0.33 | 0.27 | 0.24 | -0.01 |
| Average Basic Shares Outstanding | 80.87M | 78.97M | 78.62M | 79.52M | 78.86M |
| Average Diluted Shares Outstanding | 86.53M | 83.42M | 82.39M | 84.53M | 78.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |